For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
IO Biotech Inc (NASDAQ: IOBT) closed the day trading at $2.05 down -1.91% from the previous closing price of $2.09. In other words, the price has decreased by -$1.91 from its previous closing price. On the day, 2.73 million shares were traded. IOBT stock price reached its highest trading level at $2.43 during the session, while it also had its lowest trading level at $1.9625.
Ratios:
For a better understanding of IOBT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.96 and its Current Ratio is at 1.96. In the meantime, Its Debt-to-Equity ratio is 5.26 whereas as Long-Term Debt/Eq ratio is at 4.77.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 30 ’25 when Hunter Heidi bought 15,000 shares for $1.39 per share. The transaction valued at 20,884 led to the insider holds 15,000 shares of the business.
Ahmad Qasim Iftikhar bought 31,350 shares of IOBT for $26,553 on Dec 23 ’24. The Chief Medical Officer now owns 31,350 shares after completing the transaction at $0.85 per share. On Dec 23 ’24, another insider, Zocca Mai-Britt, who serves as the Chief Executive Officer of the company, bought 12,500 shares for $0.81 each. As a result, the insider paid 10,120 and bolstered with 49,891 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IOBT now has a Market Capitalization of 135055840 and an Enterprise Value of 117916112.
Stock Price History:
The Beta on a monthly basis for IOBT is 0.44, which has changed by 0.2974683 over the last 52 weeks, in comparison to a change of 0.14064062 over the same period for the S&P500. Over the past 52 weeks, IOBT has reached a high of $2.79, while it has fallen to a 52-week low of $0.66. The 50-Day Moving Average of the stock is 21.62%, while the 200-Day Moving Average is calculated to be 78.22%.
Shares Statistics:
Over the past 3-months, IOBT traded about 2.86M shares per day on average, while over the past 10 days, IOBT traded about 16418980 shares per day. A total of 65.88M shares are outstanding, with a floating share count of 48.43M. Insiders hold about 26.49% of the company’s shares, while institutions hold 20.14% stake in the company. Shares short for IOBT as of 1753920000 were 851154 with a Short Ratio of 0.30, compared to 1751241600 on 122659. Therefore, it implies a Short% of Shares Outstanding of 851154 and a Short% of Float of 2.69.
Earnings Estimates
The market rating for IO Biotech Inc (IOBT) is a result of the insights provided by 1.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$0.26, with high estimates of -$0.26 and low estimates of -$0.26.
Analysts are recommending an EPS of between -$1.1 and -$1.1 for the fiscal current year, implying an average EPS of -$1.1. EPS for the following year is -$0.93, with 2.0 analysts recommending between -$0.86 and -$0.99.
Revenue Estimates
Based on 5 analysts’ estimates, the company’s revenue will be $17.58M in the next fiscal year. The high estimate is $33.81M and the low estimate is $4.7M.
